Invivoscribe Gets CE Mark for NGS LymphoTrack Assays | GenomeWeb

NEW YORK (GenomeWeb) – Invivoscribe has received CE marking and launched next-generation sequencing-based assays for detecting clonality in hematological malignancies.

The LymphoTrack Dx TRG assay assesses T-cell receptor gamma rearrangements, while the LymphoTrack DX IGH FR1 assay assesses immunoglobulin heavy chain gene rearrangements.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.